甲状腺癌引起的大脑转移:预后因素和结果
Majid Esmaeilzadeh1, Oday Atallah1, Jörg Andreas Müller2
1Department of Neurosurgery, Hannover Medical School, 30625 Hannover, Germany.
Cancers
|July 13, 2024
概括
甲状腺癌的内转移很少见,但在诊断后几年也可能发生. 在这项研究中,从甲状腺癌中诊断出大脑转移的年轻患者 (<60岁) 显示出更好的生存率.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 内分泌学 在内分泌学.
背景情况:
- 甲状腺癌的内转移并不常见,但与更差的预后有关.
- 甲状腺癌患者的大脑转移的管理策略尚不清楚.
- 甲状腺癌患者在初始诊断几年后可能会发生大脑转移.
研究的目的:
- 分析甲状腺癌内转移的特征.
- 评估这些患者的治疗方式和结果.
- 确定影响甲状腺癌患者脑转移生存的因素.
主要方法:
- 从30年的机构数据库中对20名患有甲状腺癌和大脑转移的患者进行了回顾性分析.
- 收集的数据包括临床特征,瘤组织学,转移细节,治疗方法和生存率.
- 对患者人口统计,治疗方法和生存时间的统计分析.
主要成果:
- 诊断大脑转移时的平均年龄为64.8岁.
- 主要的组织学类型是乳头类 (10),毛囊类 (7),差分类 (3) .
- 平均存活时间为15个月;较年轻的患者 (<60岁) 的存活时间更好.
- 15名患者进行了手术切除;其他治疗包括放射治疗和TKI.
结论:
- 甲状腺癌的大脑转移可能发生在初级诊断后很晚.
- 脑转移诊断时的年龄是一个重要的预后因素.
- 没有观察到皮毛和卵泡甲状腺癌脑转移之间的生存差异.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...


